However, the antimicrobial effect of LEAP-2 seems to be predominantly assigned to bacterial infection given that enterocytes expressed less LEAP-2 in response to virus infections by human immunodeficiency virus (HIV) and hepatitis C virus (HCV) (21). This evidence concerns the gene LEAP2 and viral infectious disease.